<DOC>
	<DOCNO>NCT01108302</DOCNO>
	<brief_summary>This cluster randomize community-based trial design test hypothesis intramuscular administration 10 IU oxytocin Uniject™ third stage labor Auxiliary Nurse Midwife ( ANM ) birth occur home , Sub-Centers Primary Health Centers Bagalkot , India reduce risk postpartum hemorrhage 44 % ( 9 % 5 % ) relative home birth attend type provider provide intervention drug . The study also document correct use oxytocin Uniject , adverse maternal fetal event associate inappropriate use number indicator reflect programmatic feasibility implement intervention .</brief_summary>
	<brief_title>Effectiveness , Safety Feasibility Auxiliary Nurse Midwives ' ( ANM ) Use Oxytocin Uniject™ Prevent Postpartum Hemorrhage India</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>gestational age &gt; =28 wks enrollment anticipate spontaneous vaginal delivery hemoglobin &gt; =8 gm/dl delivery home , subcenter , primary health center delivery attend Auxilliary Nurse Midwife previous caesareansection schedule caesareansection antepartum bleed current pregnancy blood pressure &gt; 140mm Hg systolic &gt; 90mm Hg diastolic active labor time recruitment high risk medical condition ( diabetes , cardiac ailment , seizure , placenta previa , anticipate breech delivery</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>uterotonic</keyword>
	<keyword>oxytocin</keyword>
	<keyword>randomize trial</keyword>
	<keyword>India</keyword>
	<keyword>community</keyword>
	<keyword>hemorrhage</keyword>
</DOC>